Skip to main content
. 2022 Jan 5;40(6):546–555. doi: 10.1200/JCO.21.01589

FIG 2.

FIG 2.

Sample size differences between a traditional time-to-event end point (PFS or OS; in blue) and a binary surrogate end point (PCR; in red) in a phase III study design with power of 80% and two-sided type I error 5%. HR, hazard ratio; OR, odds ratio; OS, overall survival; pCR, pathologic complete response; PFS, progression-free survival.